AK

Aravind Krishnan Bindhu Sasikumar

Active Director Director DIN 11498795
DIN 11498795 First appointment Jan 2026 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Aravind Krishnan Bindhu Sasikumar

Data last updated:

Aravind Krishnan Bindhu Sasikumar is a Director at Nexiva Pharmaceuticals Private Limited (since 2026). The company operates in Pharma.

DIN 11498795
Primary Designation Director
Industry Pharma
First Appointment 21 Jan 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director21 Jan 20262026Active

Board colleagues of Aravind Krishnan Bindhu Sasikumar

NameDINCompanyDesignation
Visakh Krishnankutty11498796Nexiva Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Nexiva Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Aravind Krishnan Bindhu Sasikumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Aravind Krishnan Bindhu Sasikumar

Aravind Krishnan Bindhu Sasikumar currently holds 1 directorship: Nexiva Pharmaceuticals Private Limited (Director, since 21 Jan 2026).

Aravind Krishnan Bindhu Sasikumar was first appointed on 21 Jan 2026 as Director at Nexiva Pharmaceuticals Private Limited.

The current boards of Aravind Krishnan Bindhu Sasikumar's companies include Visakh Krishnankutty (Nexiva Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available